Trademark: 97240377
Status Date
Monday, January 8, 2024
Filing Date
Wednesday, January 26, 2022
Published for Opposition
Tuesday, May 24, 2022
5 pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
Jan 10, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 8, 2024
Sou Extension 3 Granted
Jan 8, 2024
Sou Extension 3 Filed
Jan 8, 2024
Sou Teas Extension Received
Jul 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 18, 2023
Sou Extension 2 Granted
Jul 18, 2023
Sou Extension 2 Filed
Jul 18, 2023
Sou Teas Extension Received
Dec 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 12, 2022
Sou Extension 1 Granted
Dec 12, 2022
Sou Extension 1 Filed
Dec 12, 2022
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 19, 2022
Approved For Pub - Principal Register
Apr 14, 2022
Assigned To Examiner
Jan 31, 2022
New Application Office Supplied Data Entered
Jan 29, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
